Human Immunodeficiency Virus and Leprosy Coinfection: Challenges in Resource-Limited Setups

Table 1

Clinical, immunological, and virological parameters of an HIV-1-leprosy coinfected patient in western Kenya.

EVENT	Weight (kg)	CD4 count (Cells/mL)	CD4%	Plasma viral load (copies/mL)
Enrolment	65	145	10
ART initiated 1 month later
5 months*	66	272	16
12 months*	64	154	13
15 months*	65	152	13
23 months*	62	192	11
27 months*	58	110	8
29 months*				1,084,798
32 months*	62	169	11
35 months *				433,376
40 months*	60	155	13
45 months*	55	195	7
47 months: Switch to second-line ART
6 months**	60	320	11
7 months**	Started antileprosy chemotherapy
13 months**				188

*After ART initiation.
**After initiation of second-line ART.